|
||
Dexedrine 15mg Uses |
||
Narcolepsy
Adult: Initially, 5-10 mg daily in divided doses, increased by 5-10 mg every wk. Maintenance to be given in 2-4 divided doses. Max: 60 mg daily.
Child: 6-12 yr Initially, 5 mg daily in divided doses, increased by 5 mg every wk. Maintenance to be given in 2-4 divided doses. Max: 60 mg daily.
Elderly: Initially, 5 mg daily in divided doses, increased by 5 mg every wk. Maintenance to be given in 2-4 divided doses. Max: 60 mg daily.
Attention deficit hyperactivity disorder
Child: 3-5 yr As immediate-release tab or soln: Initially, 2.5 mg daily, raised in increments of 2.5 mg at wkly intervals; ≥6 yr Initially, 5 mg once or twice daily, increased if necessary by 5 mg at wkly intervals. Max: 20 mg daily; older childn may require up to 40 mg or more daily.
Adult : PO Initial: 5-10 mg/day in divided doses, increased by 5-10 mg every wk. Maintenance to be given in 2-4 divided doses. Max: 60 mg/day.
Severe HTN w/ β-blockers. May diminish effects of other antihypertensives (e.g. guanethidine) and similar drugs. Increased risk of CV effects (e.g. arrhythmias) w/ TCAs or volatile liq anaesth (e.g. halothane). Urinary excretion is reduced by urinary alkalinisers and increased by acidifiers. May delay absorption of ethosuximide, phenobarbital and phenytoin. Stimulant effects are inhibited by chlorpromazine, haloperidol and lithium. Inhibition of metabolism and excretion w/ disulfiram.
Potentially Fatal: Increased risk of hypertensive crisis w/ patients being treated w/ MAOIs or w/in 14 days of stopping MAOI treatment.
Insomnia, night terrors, nervousness, restlessness, irritability, euphoria, fatigue, depression; dryness of the mouth, anorexia, abdominal cramps and other GI disturbances; headache, dizziness, tremor, sweating; tachycardia, palpitations, MI, increased or decreased BP, altered libido, impotence; hallucinations, delusional thinking, mania, seizures, stroke; muscle damage w/ associated rhabdomyolysis and renal complications. Rarely, cardiomyopathy.
Patient w/ CV disease including moderate to severe HTN, structural cardiac abnormalities, cardiomyopathy, advanced arteriosclerosis; hyperthyroidism, glaucoma, hyperexcitability or agitated states, phaeochromocytoma, porphyria, Tourette's syndrome or similar dystonias; history of drug or alcohol abuse. Concomitant use w/ MAOIs or w/in 14 days of MAOI treatment.
Dexamfetamine in Canada.
List of Dexedrine 15mg substitutes (brand and generic names) | Sort by popularity |
Unit description / dosage (Manufacturer) | Price, USD |
Amfexa (Netherlands) | |
Amfexa 10mg (United Kingdom) | |
Amfexa 20mg (United Kingdom) | |
Amfexa 5mg (United Kingdom) | |
Aspen Dexamfetamine (Australia) | |
Attentin (Germany) | |
Attentin 10mg (Germany) | |
Attentin 20mg (Germany) | |
Attentin 5mg (Germany) | |
Dexamfetamine (Canada, United States) | |
Dexamfetamine EssPharm (Norway) | |
Dexamfetamine Sulfate Central Procurement (Malta) | |
Dexamfetamine Sulfate Martindale (United Kingdom) | |
Dexamfetaminesulfaat DMB (Netherlands) | |
Dexamphetamine PSM (New Zealand) | |
Dexamphetamine Tablets (Australia, New Zealand) | |
Dexedrine 10mg (Canada) | |
Dexedrine 5mg (Canada) | |
Dextroamphetamine Sulfate (United States) | |
100 capsule in 1 bottle | |
Dextroamphetamine Sulfate capsule, extended release 15 mg/1 (Actavis Pharma, Inc. (US)) | |
Dextroamphetamine Sulfate tablet 10 mg/1 (American Health Packaging (US)) | |
Dextroamphetamine Sulfate tablet 30 mg/1 (Mikart, Inc. (US)) | |
Dextroamphetamine Sulfate tablet 5 mg/1 (Zydus Pharmaceuticals (USA, US) Inc.) | |
Dextroamphetamine Sulfate tablet 7.5 mg/1 (Mikart, Inc. (US)) | |
Dextroamphetamine Sulfate capsule, extended release 10 mg/1 (Barr Laboratories Inc. (US)) | |
Dextroamphetamine Sulfate solution 5 mg/5mL (Mikart, Inc. (US)) | |
Dextroamphetamine Sulfate capsule, extended release 5 mg/1 (Mayne Pharma Inc. (US)) | |
Dextroamphetamine Sulfate tablet 2.5 mg/1 (Mikart, Inc. (US)) | |
Dextroamphetamine Sulfate tablet 15 mg/1 (Mikart, Inc. (US)) | |
Dextroamphetamine Sulfate tablet 20 mg/1 (Mikart, Inc. (US)) | |
Dextroamphetamine Sulfate Barr (United States) | |
Dextroamphetamine Sulfate Mallinckrodt (United States) | |
Dextroamphetamine Sulfate Mikart (United States) | |
Dextroamphetamine Sulfate Nesher (United States) | |
Dextroamphetamine Sulfate Outlook (United States) |
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|